What were you most interested in seeing on our Facebook page last year? Here's a round-up of the top 10 most popular Facebook posts of 2015.
“We have a righteous purpose,” says Richard “Rick” Moran, Ph.D., a preeminent scientist at VCU Massey Cancer Center. “I ask my research students to walk through the oncology clinic every day to refresh their memories as to why we are here. The patient is the very real endpoint for research.”
Martin Lenhardt, Ph.D., was relegated to bed on Oct. 10, with little to no energy or chance of leaving the hospital in the near future, even for a day. Still, at Virginia Commonwealth University’s Massey Cancer Center, as he lay in bed surrounded by family and friends, he was allowed to play his rightful part as the proud father of the bride to his youngest daughter Megan Kinnison.
Recently, the National Cancer Institute hosted a Twitter on “Genomics and Precision Medicine in Oncology.” VCU Massey Cancer Center medical oncologist Andrew Poklepovic, M.D., who is also a member of the Developmental Therapeutics research program at Massey and assistant professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine, weighed in as the moderator posed a series of questions.
The gene p53 has been described as the “guardian of the genome” due to its prominent role in preventing genetic mutations. More than half of all cancers are thought to originate from p53 mutations or loss of function, and now a recent study by VCU Massey Cancer Center scientist Richard Moran, Ph.D., explains why.